These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17661729)

  • 21. Emerging drugs in peripheral arterial disease.
    Tulsyan N; Ouriel K; Kashyap VS
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies.
    Mangiafico RA; Fiore CE
    Curr Vasc Pharmacol; 2009 Jul; 7(3):394-413. PubMed ID: 19601864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
    Grouse JR; Allan MC; Elam MB
    J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What constitutes best medical therapy for peripheral arterial disease?
    Burns P; Lima E; Bradbury AW
    Eur J Vasc Endovasc Surg; 2002 Jul; 24(1):6-12. PubMed ID: 12127842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 26. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral artery disease: current insight into the disease and its diagnosis and management.
    Olin JW; Sealove BA
    Mayo Clin Proc; 2010 Jul; 85(7):678-92. PubMed ID: 20592174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of peripheral arterial disease.
    Aronow WS
    Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
    Hiatt WR; Krantz MJ
    Vasc Med; 2006 Feb; 11(1):55-60. PubMed ID: 16669416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical management of peripheral arterial disease: a therapeutic algorithm.
    Lumsden AB; Rice TW
    J Endovasc Ther; 2006 Feb; 13 Suppl 2():II19-29. PubMed ID: 16511954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral arterial disease in women.
    Aronow WS
    Maturitas; 2009 Dec; 64(4):204-11. PubMed ID: 19853389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of peripheral arterial disease.
    Regensteiner JG; Hiatt WR
    J Vasc Interv Radiol; 1994; 5(5):669-77. PubMed ID: 8000114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P; Jezovnik MK
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease.
    Hirsch AT; Treat-Jacobson D; Lando HA; Hatsukami DK
    Vasc Med; 1997; 2(3):243-51. PubMed ID: 9546975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.
    Momsen AH; Jensen MB; Norager CB; Madsen MR; Vestersgaard-Andersen T; Lindholt JS
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):463-74. PubMed ID: 19586783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is aspirin still the drug of choice for management of patients with peripheral arterial disease?
    Poredos P; Jezovnik MK
    Vasa; 2013 Mar; 42(2):88-95. PubMed ID: 23485835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The future prospects of antithrombotic therapy in peripheral vasculopathy].
    Violi F; Loffredo L; Annessi M
    Ann Ital Med Int; 1999; 14(3):185-91. PubMed ID: 10566184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral arterial disease in the elderly: recognition and management.
    Aronow H
    Am J Cardiovasc Drugs; 2008; 8(6):353-64. PubMed ID: 19159122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.